Page 204 - Effective healthcare cost containment policies Using the Netherlands as a case study - Niek W. Stadhouders
P. 204

Berenson, R., Hash, M., Ault, T., Fuchs, B., Maxwell, S., Potetz, L., and Zuckerman, S. (2008). Cost Containment in Medicare: A Review of What Works and What Doesn't. AARP.
Bero, L., Grilli, R., Grimshaw, J., and Oxman, A. (1998). The cochrane effective practice and organisation of care review group. The Cochrane database of Systematic Reviews Issue 3.
Berta, P., Callea, G., Martini, G., and Vittadini, G. (2010). The effects of upcoding, cream skimming and readmissions on the Italian hospitals efficiency: a population-based investigation. In "Economic Modelling", Vol. 27, pp. 812-821.
Berta, P., Seghieri, C., and Vittadini, G. (2013). Comparing health outcomes among hospitals: the experience of the Lombardy Region. In "Health care management science", Vol. 16, pp. 245-257. Berwick, D. M., and Hackbarth, A. D. (2012). Eliminating waste in US health care. Jama 307, 1513-1516.
Berwick, D. M., Nolan, T. W., and Whittington, J. (2008). The triple aim: care, health, and cost. Health Affairs 27, 759-769.
Bes, R. E., Curfs, E. C., Groenewegen, P. P., and de Jong, J. D. (2017). Selective contracting and channelling patients to preferred providers: A scoping review. Health Policy 121, 504-514. Beukers, P. D. C., Kemp, R. G. M., and Varkevisser, M. (2014). Patient hospital choice for hip
replacement: empirical evidence from the Netherlands. The European Journal of Health
Economics 15, 927-936.
Bevan, G., and van de Ven, W. P. M. M. (2010). Choice of providers and mutual healthcare purchasers: can
the English National Health Service learn from the Dutch reforms? Health Economics, Policy and
Law 5, 343-363.
Biørn, E., Hagen, T. P., Iversen, T., and Magnussen, J. (2003). The effect of activity-based financing on
hospital efficiency: a panel data analysis of DEA efficiency scores 1992–2000. Health care
management science 6, 271-283.
Biro, A., and Hellowell, M. (2016). Public-private sector interactions and the demand for supplementary
health insurance in the United Kingdom. Health Policy 120, 840-847.
Blazquez-Fernandez, C., Cantarero, D., and Perez, P. (2014). Disentangling the heterogeneous income
elasticity and dynamics of health expenditure. Applied Economics 46, 1839-1854.
Blendon, R. J., Brodie, M., Benson, J. M., Altman, D. E., Levitt, L., Hoff, T., and Hugick, L. (1998). Understanding The Managed Care Backlash: Regardless of how well their plans perform today, people in managed care have greater fears than their traditionally insured peers do that their plan
will fall short when they really need it. Health Affairs 17, 80-94.
Bloem, B. R., Rompen, L., Vries, N. M. d., Klink, A., Munneke, M., and Jeurissen, P. (2017).
ParkinsonNet: A low-cost health care innovation with a systems approach from the Netherlands.
Health Affairs 36, 1987-1996.
Bloom, J. R., Wang, H., Kang, S. H., Wallace, N. T., Hyun, J. K., and Hu, T.-w. (2011). Capitation of
public mental health services in Colorado: a five-year follow-up of system-level effects.
Psychiatric services (Washington, D.C.) 62, 179-85.
Blumenthal, D., Stremikis, K., and Cutler, D. (2013). Health Care Spending — A Giant Slain or Sleeping?
New England Journal of Medicine 369, 2551-2557.
Bobinac, A., van Exel, J., Rutten, F. F. H., and Brouwer, W. B. F. (2014). The Value of a QALY:
Individual Willingness to Pay for Health Gains Under Risk. PharmacoEconomics 32, 75-86. Bobinac, A., Van Exel, N., Rutten, F. F., and Brouwer, W. B. (2010). Willingness to pay for a quality-
adjusted life-year: the individual perspective. Value in Health 13, 1046-1055.
Böhm, K., Schmid, A., Götze, R., Landwehr, C., and Rothgang, H. (2013). Five types of OECD healthcare
systems: Empirical results of a deductive classification. Health Policy 113, 258-269.
Boisverf, R. N. (1982). THE TRANSLOG PRODUCTION FUNCTION:‘ITS PROPERTBES, ITS
SEVERAL INTERPRETATIONS AND ESHMATION PROBLEMS.
Bonastre, J., Chevalier, J., Van der Laan, C., Delibes, M., and De Pouvourville, G. (2014). Access to
innovation: Is there a difference in the use of expensive anticancer drugs between French
hospitals? In "Health policy", Vol. 116, pp. 162-169.
Boonen, L. H. H. M., and Schut, F. T. (2010). Preferred providers and the credible commitment problem in
health insurance: first experiences with the implementation of managed competition in the Dutch
health care system. Health Economics, Policy and Law 6, 219-235.
Boterenbrood, R. (2014). Income smoothing by Dutch hospitals. Journal of Accounting and Public Policy
33, 510-524.
Boyne, G. A. (2002). Public and private management: what’s the difference? Journal of management
studies 39, 97-122. 196






















































   202   203   204   205   206